ORAGENICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
ORAGENICS, INC. (OGEN) had Deferred Tax Assets, Operating Loss Carryforwards of $40.11 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-16
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $40.11M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $41.07M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $39.81M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $37.71M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $40.11M 10-K · filed 2026-03-16 |
| 2024-12-31 | $41.07M 10-K · filed 2026-03-16 |
| 2023-12-31 | $39.81M 10-K · filed 2025-03-14 |
| 2022-12-31 | $37.71M 10-K · filed 2024-03-29 |
| 2021-12-31 | $36.34M 10-K · filed 2023-04-17 |
| 2020-12-31 | $35.74M 10-K/A · filed 2022-07-29 |
| 2019-12-31 | $29.42M 10-K · filed 2021-03-01 |
| 2018-12-31 | $25.63M 10-K · filed 2020-03-04 |
| 2017-12-31 | $23.34M 10-K · filed 2019-03-29 |
| 2016-12-31 | $33.19M 10-K · filed 2018-02-16 |
| 2015-12-31 | $30.70M 10-K · filed 2017-02-27 |
| 2014-12-31 | $26.44M 10-K · filed 2016-03-30 |
| 2013-12-31 | $24.34M 10-K · filed 2015-02-27 |
| 2012-12-31 | $18.57M 10-K · filed 2014-02-28 |
| 2011-12-31 | $13.68M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |